Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 47952-47953 [E8-18904]

Download as PDF 47952 Federal Register / Vol. 73, No. 159 / Friday, August 15, 2008 / Notices Dated: August 11, 2008. Christine M. Branche, Acting Director, National Institute for Occupational Safety and Health. [FR Doc. E8–18909 Filed 8–14–08; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Request for Planning Ideas for Development of an AHRQ Innovations Research Portfolio Agency for Healthcare Research and Quality (AHRQ), HHS. AGENCY: ACTION: Notice of Request for Ideas. SUMMARY: AHRQ is establishing a new research portfolio, the Innovations Portfolio. The Portfolio goal is to identify and support research that has the potential to accelerate improvements in the organization, delivery, and management of healthcare. AHRQ seeks ideas on priority topics and activities that should be addressed as components of the Innovations Portfolio. Please submit comments no later than October 14, 2008. DATES: Submissions should be brief (no more than three pages per recommendation), and should be in the form of a letter or e-mail, preferably with an electronic file in a standard word processing format as an e-mail attachment. Responses to this request should be submitted to Francis D. Chesley, Jr., M.D., Agency for Health Care Research and Quality, 540 Gaither Road, Room 2034, Rockville, MD 20850, FAX: (301) 427–1562, e-mail: francis.chesley@ahrq.hhs.gov. In order to facilitate handling of submissions, please include full information about the person submitting the recommendation: (a) Name, (b) title; (c) organization, (d) mailing address, (e) telephone number, and (f) e-mail address. Please do not use acronyms. ADDRESSES: mstockstill on PROD1PC66 with NOTICES FOR FURTHER INFORMATION CONTACT: Francis D. Chesley, Jr., M.D., (301) 427– 1449 or at francis.chesley@ahrg.hhs.gov. All responses will be available for public inspection at AHRQ’s Office of Extramural Research, Education, and Priority Populations weekdays between 8:30 a.m. and 5 p.m. Arrangements for reviewing the submissions may be made by calling (301) 427–1449. SUPPLEMENTARY INFORMATION: VerDate Aug<31>2005 19:03 Aug 14, 2008 Jkt 214001 Background The Innovations Portfolio is focused on creating resources and opportunity for exploration and discovery. The Innovations Portfolio was created to identify and support research that has the potential for high impact. These ideas will be novel and span a diverse array of disciplines. The portfolio will foster and nurture ideas and projects that have the potential to lead to highly innovative solutions that may lead to significant advances in healthcare organization, delivery, and management. Research and activities supported under the Innovations Portfolio will reflect ideas substantially different from those already being pursued by AHRQ. The portfolio will fund a transformative research agenda to solve pressing healthcare problems. Thus, the main focus of the portfolio is problem solving in order to accelerate improvement in healthcare. Ideas are sought for topics to be supported by the Innovations Portfolio. Ideas are also sought regarding specific strategies to foster innovative approaches and programs. Comments and ideas may address new and emerging priority issues and areas that should be the focus of research in the Innovations Portfolio, mechanisms for identifying and engaging partners for this important work, or any related topic. Dated: August 4, 2008. Carolyn M. Clancy, Director. [FR Doc. E8–18671 Filed 8–14–08; 8:45 am] BILLING CODE 4160–90–M contact person listed below. If you will require a sign language interpretator, or have other special needs, please notify the contact person by 4:30 E.S.T. on September 9, 2008. Purpose: The Interagency Committee on Smoking and Health advises the Secretary, Department of Health and Human Services, and the Assistant Secretary for Health in the (a) coordination of all research and education programs and other activities within the Department and with other federal, state, local and private agencies and (b) establishment and maintenance of liaison with appropriate private entities, federal agencies, and state and local public health agencies with respect to smoking and health activities. Matters to be Discussed: The agenda will focus on ‘‘NicotineAddiction.’’ Contact Person for More Information: Substantive program information as well as summaries of the meeting and roster of committee members may be obtained from the internet at http: //www.cdc.gov/tobacco in mid-December or from Ms. Monica L. Swann, Management and Program Analyst, Office on Smoking and Health, Centers for Disease Control and Prevention, 4770 Buford Highway, M/S K50, Atlanta, Georgia 30341, Telephone: 770–488–5278. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: August 11, 2008. Lorenzo J. Falgiano, Acting Director, Management Analysis and Service Office, Centers for Disease Control and Prevention. [FR Doc. E8–18899 Filed 8–14–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention The National Center for Chronic Disease Prevention and Health Promotion In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the following meeting. Name: Interagency Committee on Smoking and Health. Time and Date: 9 a.m.—4:30 p.m., September 16, 2008. Place: Hilton Washington Embassy Row, Ambassador Room, 2015 Massachusetts Avenue, NW., Washington, DC 20036. Telephone: 202–939–4124. Status: Open to the public, limited only by the space available. Those who wish to attend are encouraged to register with the PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention, announces the following meeting for the aforementioned subcommittee: Time and Date: 9:30 a.m.—5 p.m., August 20, 2008. Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, Kentucky 41018. Telephone (859)334–4611, Fax (859)334– 4619. E:\FR\FM\15AUN1.SGM 15AUN1 Federal Register / Vol. 73, No. 159 / Friday, August 15, 2008 / Notices mstockstill on PROD1PC66 with NOTICES Status: Open to the public, but without a public comment period. To access by conference call dial the following information 1(866)659–0537, Participant Pass Code 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development ofprobability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2009. Purpose: The Advisory Board is charged with (a) Providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee for Dose Reconstruction Reviews was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. Matters to be Discussed: The agenda for the Subcommittee meeting includes a discussion of cases under review from the 6th, 7th, and 8th sets of individual dose reconstructions; and selection of cases for future review. The agenda is subject to change as priorities dictate. ABRWH determines that agency business requires its consideration of this matter on less than 15 days notice to the public and that no earlier notice of this meeting was possible. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact personbelow well in advance of the meeting. Contact Person for More Information: Christine Branche, Ph.D., Executive Secretary, NIOSH, CDC, 395 E. Street, SW., VerDate Aug<31>2005 19:03 Aug 14, 2008 Jkt 214001 Suite 9200, Washington, DC 20201, Telephone (513)533–6800, Toll Free 1(800)CDC–INFO, E-mail ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 11, 2008. Lorenzo J. Falgiano, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–18904 Filed 8–14–08; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–10260 and CMS– 10256] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the Agency’s function; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: New collection; Title of Information Collection: Medicare Advantage (MA) Disclosure Requirements; Use: The information collection requirements are mandated by 42 CFR 422.111 and 422.80. MA organizations will be required to notify plan members of the coming year’s changes using a combined standardized document. MA organizations and potential MA organizations (applicants) will use the information to comply with AGENCY: PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 47953 the eligibility requirements and the MA contract requirements. CMS will use this information to ensure that correct information is disclosed to Medicare beneficiaries, both potential enrollees and enrollees. Form Number: CMS– 10260 (OMB# 0938–New); Frequency: Yearly; Affected Public: Business or other for-profit; Number of Respondents: 670; Total Annual Responses: 670; Total Annual Hours: 8040. 2. Type of Information Collection Request: New collection; Title of Information Collection: Medicare Care Management performance (MCMP) Demonstration; Use: Section 649 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) requires the Secretary of the U.S. Department of Health and Human Services to establish a pay-forperformance (P4P) demonstration program with physicians to meet the needs of eligible beneficiaries through the adoption and use of health information technology (HIT) and evidence-based outcome measures. The Medicare Care Management Performance Demonstration was established in response to the MMA. Mathematica Policy Research, Inc. is conducting an evaluation of the MCMP on behalf of CMS. The goals of the three-year demonstration are to improve quality of care to eligible fee-for-service Medicare beneficiaries and encourage the implementation and use of HIT. The specific objectives are to promote continuity of care, help stabilize medical conditions, prevent or minimize acute exacerbations of chronic conditions, and reduce adverse health outcomes. The MMA authorizes a total of four sites in both urban and rural areas. The demonstration sites are in Arkansas, California, Massachusetts, and Utah. The MCMP demonstration will target practices serving at least 50 traditional fee-for-service Medicare beneficiaries with congestive heart failure, coronary heart disease, and diabetes for whom they provide primary care. An impact analysis using a comparison group design will be conducted as part of the evaluation. Physician practices in selected nondemonstration States that match most closely those in demonstration States on key factors will make up the comparison group. The impact analysis will use data from four data sources: (1) A beneficiary survey, (2) a physician survey, (3) Medicare claims and eligibility data, and (4) practice-specific data. This request relates to the two surveys. Form Number: CMS–10256 (OMB# 0938– New); Frequency: Once; Affected Public: E:\FR\FM\15AUN1.SGM 15AUN1

Agencies

[Federal Register Volume 73, Number 159 (Friday, August 15, 2008)]
[Notices]
[Pages 47952-47953]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18904]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory 
Board on Radiation and Worker Health (ABRWH), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention, announces the following meeting for the aforementioned 
subcommittee:

    Time and Date: 9:30 a.m.--5 p.m., August 20, 2008.
    Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, 
Kentucky 41018. Telephone (859)334-4611, Fax (859)334-4619.

[[Page 47953]]

    Status: Open to the public, but without a public comment period. 
To access by conference call dial the following information 
1(866)659-0537, Participant Pass Code 9933701.

    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing 
advice on the development ofprobability of causation guidelines that 
have been promulgated by the Department of Health and Human Services 
(HHS) as a final rule; advice on methods of dose reconstruction 
which have also been promulgated by HHS as a final rule; advice on 
the scientific validity and quality of dose estimation and 
reconstruction efforts being performed for purposes of the 
compensation program; and advice on petitions to add classes of 
workers to the Special Exposure Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2009.
    Purpose: The Advisory Board is charged with (a) Providing advice 
to the Secretary, HHS, on the development of guidelines under 
Executive Order 13179; (b) providing advice to the Secretary, HHS, 
on the scientific validity and quality of dose reconstruction 
efforts performed for this program; and (c) upon request by the 
Secretary, HHS, advise the Secretary on whether there is a class of 
employees at any Department of Energy facility who were exposed to 
radiation but for whom it is not feasible to estimate their 
radiation dose, and on whether there is reasonable likelihood that 
such radiation doses may have endangered the health of members of 
this class. The Subcommittee for Dose Reconstruction Reviews was 
established to aid the Advisory Board in carrying out its duty to 
advise the Secretary, HHS, on dose reconstruction.
    Matters to be Discussed: The agenda for the Subcommittee meeting 
includes a discussion of cases under review from the 6th, 7th, and 
8th sets of individual dose reconstructions; and selection of cases 
for future review.
    The agenda is subject to change as priorities dictate.
    ABRWH determines that agency business requires its consideration 
of this matter on less than 15 days notice to the public and that no 
earlier notice of this meeting was possible.
    In the event an individual cannot attend, written comments may 
be submitted. Any written comments received will be provided at the 
meeting and should be submitted to the contact personbelow well in 
advance of the meeting.
    Contact Person for More Information: Christine Branche, Ph.D., 
Executive Secretary, NIOSH, CDC, 395 E. Street, SW., Suite 9200, 
Washington, DC 20201, Telephone (513)533-6800, Toll Free 1(800)CDC-
INFO, E-mail ocas@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: August 11, 2008.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E8-18904 Filed 8-14-08; 8:45 am]
BILLING CODE 4163-19-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.